Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Change in Account Payables (2019 - 2025)

Outset Medical (OM) has disclosed Change in Account Payables for 7 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 156.01% to -$1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.3 million, a 69.05% decrease, with the full-year FY2025 number at -$3.3 million, down 69.05% from a year prior.
  • Change in Account Payables was -$1.1 million for Q4 2025 at Outset Medical, down from $338000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $3.3 million in Q1 2022 to a low of -$4.1 million in Q2 2021.
  • A 5-year average of -$213800.0 and a median of -$117000.0 in 2023 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: surged 533.57% in 2023, then tumbled 819.32% in 2024.
  • Outset Medical's Change in Account Payables stood at -$915000.0 in 2021, then rose by 22.84% to -$706000.0 in 2022, then soared by 533.57% to $3.1 million in 2023, then plummeted by 114.41% to -$441000.0 in 2024, then tumbled by 156.01% to -$1.1 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Change in Account Payables are -$1.1 million (Q4 2025), $338000.0 (Q3 2025), and $270000.0 (Q2 2025).